All CJC-1295 (No DAC) + Ipamorelin certificates

CJC-1295 (No DAC) + Ipamorelin 10 mg Certificate of Analysis Batch APL-CJCIP10-2607-02

CJC-1295 (No DAC) + Ipamorelin 10 mg from batch APL-CJCIP10-2607-02 was analysed on 17 July 2026 and measured 99.56% combined purity across Ipamorelin and CJC-1295 (No DAC) by HPLC / Mass Spectrometry, passing all 5 release tests.

Combined purity
99.56%
Components
Ipamorelin, CJC-1295 (No DAC)
Result
All 5 tests passed
Tested
17 July 2026
Method
HPLC / Mass Spectrometry
Net content
10.03 mg

Independent verification

CJC-1295 (No DAC) + Ipamorelin 10 mg is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 99.16% purity by UPLC-MS/MS, analysed 27 August 2026 on lot APL-CJCIP10-2608-01, net content Ipamorelin 5.10 mg, CJC-1295 (No DAC) 5.29 mg, verification code OZ-HPLCMS-JKJ2; bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL, analysed 28 August 2026, verification code OZ-ENDOTX-TPA1.

Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

The certificate as issued is reproduced below — pinch to zoom on a phone, or use Print / Save as PDF for a full-size copy.

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 1 of 3

Certificate of Analysis CJC-1295 (No DAC) + Ipamorelin 10 mg Batch APL-CJCIP10-2607-02
Compound Mix
CJC-1295 (No DAC) + Ipamorelin
Lot Number
APL-CJCIP10-2607-02
Analysis Date
17 July 2026
Method
HPLC / Mass Spectrometry
Purity
99.56%
Net Content
10.03 mg
CJC-1295 (No DAC) + Ipamorelin vial
Net Content
  • Ipamorelin5.02 mg
  • CJC-1295 (No DAC)5.01 mg
Form
Lyophilised Powder
Manufactured
July 2026
Issued
18 July 2026
Document ID
APL-COA-CJCIP10-2607-02
Verification Code
Batch traceable

High Performance Liquid Chromatography (HPLC-UV) Chromatogram

mAUPDA 214 nm018837556375033.544.555.566.5 min 3.570Ipamorelin3.6344.077CJC-1295 (No DAC)4.3104.6525.853

Components resolved at 3.57 min (Ipamorelin, 40.61%), 4.08 min (CJC-1295 (No DAC), 58.95%); combined peptide area 99.56%. No single impurity peak exceeds 0.19%.

Peak List

Peaks detected: 6
#Time (min)Area% AreaAssignment
13.5702,947,89440.610Ipamorelin
23.6349,2620.130—
34.0774,278,85958.950CJC-1295 (No DAC)
44.31013,3950.190—
54.6524,2780.060—
65.8534,2600.060—

Analytical Results

TestSpecificationResultStatus
AppearanceWhite/Off-White Lyophilised PowderConformsPASS
Identity (MS)All components confirmedConfirmedPASS
Purity (HPLC)≥98.0% combined99.56%PASS
Total Peptide Content95–105%99.4%PASS
Endotoxins<0.5 EU/mg<0.25 EU/mgPASS

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 2 of 3

Ipamorelin

PubChem CID: 9831659 · CAS Number: 170851-70-4

Formula: C38H49N9O5 · MW: 711.85 g/mol · In this vial: 5.02 mg

SequenceAib-His-D-2-Nal-D-Phe-Lys-NH2

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 17 July 2026
Monitored (m/z)Detected (m/z)Relative Intensity
357356.963.8
713712.833.12

Detection assignment: Ipamorelin

Collected Mass Spectrum

Intensity ×107

0123401002003004005006007008009001000 m/z 357713

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 3 of 3

CJC-1295 (No DAC)

PubChem CID: 91971820 · CAS Number: 446262-90-4

Formula: C152H252N44O42 · MW: 3367 g/mol · In this vial: 5.01 mg

SequenceTyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 17 July 2026
Monitored (m/z)Detected (m/z)Relative Intensity
674674.431.5
843842.741.67
11231123.352.49

Detection assignment: CJC-1295 (No DAC)

Collected Mass Spectrum

Intensity ×107

0123300500700900110013001500 m/z 6748431123

Verification Protocol

  • Identity confirmed separately for each component by mass spectrometry against its own expected ion channels.
  • Purity measured by HPLC as the combined area of every assigned component peak against all integrated impurity peaks.
  • Batch traceability: this document reports the lot number printed on the vial.
  • Analysis performed in-house by Australian Peptide Labs.

Supplied for laboratory research use only. Not a therapeutic good; not for human or veterinary use.

View CJC-1295 (No DAC) + Ipamorelin in the catalogueHow to read this certificate